Technological advances in cancer care have changed the very process of treatment, as now oncologists can gain more insight into the most effective therapy for each individual patient, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology.
Technological advances in cancer care have changed the very process of treatment, as now oncologists can gain more insight into the most effective therapy for each individual patient, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology.
Transcript (slightly modified)
How are innovative therapies like precision medicine and immuno-oncology changing the cancer care landscape?
It’s really hard to think of oncology in the same way with the availability of this wealth of therapeutics that would have been unimaginable. And it’s not just this idea that we have new technologies. It’s the idea that the process for how we’re going to use these technologies is really based on something different than just iteratively trying something new for a patient in need.
Our old model of caring for patients involved first-line therapy and second-line therapy and third-line therapy based upon this idea that you’d have to move to something different than what you used before. These days, with immuno-oncologic drugs, what we’re able to do is actually really leverage the biology of the tumor in a way to target it most effectively: achieving better outcomes and also reducing toxicities.
On the flip side of this, there are things that we can learn by understanding a patient through next-generation sequencing and other genomic technologies that let us know that first-line and second-line and third-line for one person may be very radically different based upon their genetic makeup versus another patient with ostensibly the same diagnosis.
So I see these things as tools which are working in tandem to enhance patient care, so it’s a very new, very complex paradigm for delivering care unlike anything that we’ve had over the history of oncology.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More